Paperpal Prime Logo

Hepatobiliary and Pancreatic Diseases International : Impact Factor & More

eISSN: 2352-9377pISSN: 1499-3872

Key Metrics

CiteScore
5.2
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q3Hepatology
SNIP
1.1
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Hepatobiliary and Pancreatic Diseases International

Hepatobiliary and Pancreatic Diseases International Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher ELSEVIER
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2002
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Hepatobiliary and Pancreatic Diseases International ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Hepatobiliary and Pancreatic Diseases International

Multiphase enhanced computed tomography features captured by delta radiomics reveal prognosis and tumor heterogeneity in patients with hepatocellular carcinoma treated with transarterial chemoembolization.
  • 1 Aug 2026
  • Hepatobiliary & pancreatic diseases international : HBPD INT
The role of gut microbiota and metabolomics in tacrolimus-induced metabolic diseases after liver transplantation.
  • 1 Aug 2026
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Proximal splenic artery ligation improves liver reperfusion, mitigates graft injury and decreases complications after liver transplantation.
  • 1 Aug 2026
  • Hepatobiliary & pancreatic diseases international : HBPD INT
The outcomes of surgical resection versus ablation of liver metastases from neuroendocrine tumors: A systematic review.
  • 1 Aug 2026
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Modulating hepatic stellate cell senescence: A promising therapeutic strategy for liver fibrosis.
  • 1 Aug 2026
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Chinese guideline for clinical application of antithymocyte globulin in liver transplant recipients.
  • 1 Aug 2026
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Multiphase enhanced computed tomography features captured by delta radiomics reveal prognosis and tumor heterogeneity in patients with hepatocellular carcinoma treated with transarterial chemoembolization.
  • 1 Aug 2026
  • Hepatobiliary & pancreatic diseases international : HBPD INT
The role of gut microbiota and metabolomics in tacrolimus-induced metabolic diseases after liver transplantation.
  • 1 Aug 2026
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Proximal splenic artery ligation improves liver reperfusion, mitigates graft injury and decreases complications after liver transplantation.
  • 1 Aug 2026
  • Hepatobiliary & pancreatic diseases international : HBPD INT
The outcomes of surgical resection versus ablation of liver metastases from neuroendocrine tumors: A systematic review.
  • 1 Aug 2026
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Modulating hepatic stellate cell senescence: A promising therapeutic strategy for liver fibrosis.
  • 1 Aug 2026
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Chinese guideline for clinical application of antithymocyte globulin in liver transplant recipients.
  • 1 Aug 2026
  • Hepatobiliary & pancreatic diseases international : HBPD INT

FAQs on Hepatobiliary and Pancreatic Diseases International